www.fdanews.com/articles/191413-europe-recognizes-south-korea-for-safe-inspections-regulations
![Red_Approved_Stamp.gif](https://www.fdanews.com/ext/resources/test/Drug-Images4/Red_Approved_Stamp.gif?t=1578447203&width=430)
Europe Recognizes South Korea for Safe Inspections, Regulations
May 24, 2019
European regulators have given their South Korean counterparts the stamp of approval, recognizing that Korea’s regulatory framework for active ingredients align with the EU’s requirements.
The European Commission said two on-site reviews and supporting documentation showed that South Korea has the regulatory oversight to provide safe and effective active ingredients for export.
The EU also recognizes the regulatory oversight of active substances by competent authorities in the U.S., Australia, Brazil, Israel, Japan and Switzerland. Equivalence assessments are in progress for Canada and New Zealand.